Literature DB >> 19752227

The immunological impact of genetic drift in the B10.BR congenic inbred mouse strain.

Stacey L Fanning1, Michael Y Appel, Stephanie A Berger, Robert Korngold, Thea M Friedman.   

Abstract

The MHC-matched, minor histocompatibility Ag (miHA)-mismatched B10.BR-->CBA strain combination has been used to elucidate the immunobiology of graft-vs-host disease (GVHD) following allogeneic bone marrow transplantation. Studies conducted in the 1980s had established that B10.BR CD8+ T cells were capable of mediating GVHD in the absence of CD4+ T cells, and that CD4+ T cells were unable to induce lethal disease. In more recent studies with this GVHD model, we detected etiological discrepancies with the previously published results, which suggested that genetic drift might have occurred within the B10.BR strain. In particular, there was increased allorecognition of CBA miHA by B10.BR CD4+ T cells, as determined by both TCR Vbeta spectratype analysis and the induction of lethal GVHD in CBA recipients. Additionally, alloreactivity was observed between the genetically drifted mice (B10.BR/Jdrif) and mice rederived from frozen embryos of the original strain (B10.BR/Jrep) using Vbeta spectratype analysis and IFN-gamma ELISPOT assays, suggesting that new miHA differences had arisen between the mice. Furthermore, T cell-depleted B10.BR/Jdrif bone marrow cells were unable to provide long-term survival following either allogeneic or syngeneic bone marrow transplantation. Gene expression analysis revealed several genes involved in hematopoiesis that were overexpressed in the lineage-negative fraction of B10.BR/Jdrif bone marrow, as compared with B10.BR/Jrep mice. Taken together, these results suggest that genetic drift in the B10.BR strain has significantly impacted the immune alloreactive response in the GVHD model by causing altered expression of miHA and diminished capacity for survival following transplantation into lethally irradiated recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752227     DOI: 10.4049/jimmunol.0900971

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Intestinal microbiome and lymphoma development.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

2.  Competition between T cells maintains clonal dominance during memory inflation induced by MCMV.

Authors:  Holly Turula; Corinne J Smith; Finn Grey; Katherine A Zurbach; Christopher M Snyder
Journal:  Eur J Immunol       Date:  2013-03-20       Impact factor: 5.532

Review 3.  Mouse models of graft-versus-host disease: advances and limitations.

Authors:  Mark A Schroeder; John F DiPersio
Journal:  Dis Model Mech       Date:  2011-05       Impact factor: 5.758

Review 4.  Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.

Authors:  Kira G Hartman; James D Bortner; Gary W Falk; Gregory G Ginsberg; Nirag Jhala; Jian Yu; Martín G Martín; Anil K Rustgi; John P Lynch
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-29

5.  Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine.

Authors:  Jin Huk Choi; Stephen C Schafer; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2015-01-20       Impact factor: 4.939

Review 6.  Lymphoma caused by intestinal microbiota.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Int J Environ Res Public Health       Date:  2014-09-01       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.